Integral Molecular’s West Nile Virus Reporter Virus Particles (RVPs) are non-replicative, pseudoinfective viral particles that enable safe (BSL-2), easy, and high-throughput viral infectivity and neutralization assays using standard detection instrumentation. WNV RVPs are structurally intact West Nile virus-like particles produced using the CprME structural genes and ire designed to have structural and antigenic equivalence to live viruses. The WNV RVPs carry a modified viral minigenome that expresses a luciferase optical reporter gene within 24 hours of cellular infection. Protocols are provided for neutralization and infectivity assays.
Target cells are sold separately.
For more details about RVPs, their applications, and answers to frequently asked questions, visit the Reporter Virus Particle Information page. For tips on setting up your own neutralization assay, visit Pseudovirus Neutralization Assays: A How-to Guide for Getting Started.
| Product | West Nile Virus Reporter Virus Particles (RVPs) |
| Catalog Number | RVP-1650 |
| Strain | NY99 |
| Packaging | 20% FBS/DMEM |
| Recommended Input Range | 3.125 uL per well (96-well plate) |
| Target Cell Line | BHK cells, DC-SIGN stable cell line (Cat# C-BD102) |
| Lead time | 1-4 weeks |
| Shipping | Shipped on dry ice |
| Storage conditions | Store at -80°C (+/- 10°C) upon receipt |
| Size | 1.0 mL/vial |
| Warranty | Terms and Conditions (pdf) |
| SDS | Contact us for SDS |
| Protocols |
Contact us for protocols
|
| Technical Data Sheets | WNV Tech Data Sheets |
